Reviva Pharmaceuticals (NASDAQ:RVPH) stock fell 14.2% in premarket trade, after the company priced its $5M equity offering. The company said it has priced its underwritten offering of 4.76M shares and...
Source LinkReviva Pharmaceuticals (NASDAQ:RVPH) stock fell 14.2% in premarket trade, after the company priced its $5M equity offering. The company said it has priced its underwritten offering of 4.76M shares and...
Source Link
Comments